For Q1 FY2026 ended March 31, 2026, Wellgistics Health reported revenue of $1,559,563, a decline of 85.6% year-over-year. Net loss was $7,742,597, widening 76.1% from the prior year. Operating loss was $6,015,538, and diluted EPS was -$0.07. The company had $51,730 in cash, negative equity of $15,062,449, and long-term debt of $27,771,900.
•Revenue fell 85.6% YoY to $1.56M.
•Net loss widened 76.1% to $7.74M.
•Diluted EPS was -$0.07.
•Cash of $51,730; negative equity of $15.06M; long-term debt of $27.77M.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Wellgistics Health provides the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers.
It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies
Operates a retail community specialty. Formerly known as Danam Health, Inc., the company rebranded as Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.
Wellgistics Health, Inc. is a healthcare company that provides wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies across the United States. The company distributes both branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products. Additionally, Wellgistics offers third-party logistics services including warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates the DelivMeds platform, which serves as a pharmaceutical hub to facilitate prescription transfers and provide backend clinical concierge services to a network of independent pharmacies. Furthermore, the company runs a retail community specialty pharmacy. Formerly known as Danam Health, Inc., the company rebranded to Wellgistics Health, Inc. in October 2024.
Where is Wellgistics Health (WGRX) listed and what currency does it trade in?
Wellgistics Health, Inc. is listed on the Nasdaq Capital Market (NasdaqCM) under the ticker symbol WGRX. The company trades in U.S. Dollars (USD), which is the standard currency for stocks listed on U.S. exchanges. Being listed on NasdaqCM provides the company with visibility among investors and access to capital markets, while trading in USD facilitates transactions for domestic and international investors who are familiar with the U.S. dollar.
What sector and industry does Wellgistics Health (WGRX) belong to?
Wellgistics Health, Inc. operates in the Healthcare sector, specifically within the Pharmaceutical Retailers industry. As a pharmaceutical retailer, the company focuses on the wholesale distribution of pharmaceutical products to manufacturers and independent pharmacies, rather than directly dispensing medications to end consumers. This industry involves managing supply chains for prescription drugs and over-the-counter products, ensuring that pharmacies and manufacturers have access to necessary medications and healthcare items. The company's role in the pharmaceutical supply chain is critical for maintaining the availability of drugs in the U.S. market.
Where is Wellgistics Health (WGRX) headquartered and what markets does it serve?
Wellgistics Health, Inc. is headquartered in Tampa, Florida, United States. The company serves the U.S. market, focusing on pharmaceutical manufacturers and independent retail pharmacies nationwide. Its operations include distributing pharmaceutical products across the country, providing logistics services to small and mid-size manufacturers, and operating the DelivMeds platform that connects independent pharmacies. By serving independent pharmacies, Wellgistics supports local healthcare providers and helps ensure that patients in various communities have access to prescription medications and over-the-counter products.
How does Wellgistics Health (WGRX) generate revenue?
Wellgistics Health generates revenue primarily through the wholesale distribution of branded and generic pharmaceuticals, as well as over-the-counter healthcare and consumer products, to pharmaceutical manufacturers and independent retail pharmacies. The company also earns income from third-party logistics services, which include warehousing, inventory management, pick and pack, and shipping for small and mid-size pharmaceutical manufacturers. Additionally, its DelivMeds platform generates revenue by facilitating prescription transfers and providing clinical concierge services to a network of independent pharmacies. The company also operates a retail community specialty pharmacy, which contributes to its revenue stream. By offering a comprehensive suite of distribution and logistics solutions, Wellgistics positions itself as a key intermediary in the pharmaceutical supply chain.